Implications of proopiomelanocortin (POMC) mutations in humans: The POMC deficiency syndrome

Trends in Endocrinology and Metabolism

Volumn 11, Issue 1, 2000, Pages 15-22

  Krude, Heiko ^a   Grüters, Annette ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; HORMONE PRECURSOR; PROOPIOMELANOCORTIN;

ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; AMINO ACID SEQUENCE; BODY WEIGHT; CORTICOTROPIN DEFICIENCY; GENE MUTATION; GENE STRUCTURE; HAIR COLOR; HUMAN; HYPOPIGMENTATION; NOCICEPTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PRO-OPIOMELANOCORTIN;

EID: 0342657747     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(99)00213-1     Document Type: Review

References (57)

1. Chretien M.et al. From beta-lipotropin to beta-endorphin and 'pro-opio-melanocortin'. Can. J. Biochem. 57:1979;1111-1121.
2. Nakanishi S.et al. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature. 278:1979;423-427.
3. Takahashi H.et al. Complete nucleotide sequence of the human corticotropin-beta-lipotropin precursor gene. Nucleic Acids Res. 11:1983;6847-6858.
4. Takeuchi S.et al. Molecular cloning and characterization of the chicken pro-opiomelanocortin (POMC) gene. Biochem. Biophys. Acta. 1450:1999;452-459.
5. Lindberg I. The new eukaryotic precursor processing proteinases. Mol. Endocrinol. 5:1991;1361-1365.
6. Lerner A.B. The discovery of the melanotropins. A history of pituitary endocrinology. Ann. New York Acad. Sci. 680:1993;1-12.
7. Li S.J.et al. Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones. J. Neurosci. 16:1996;5182-5188.
8. Cone R. The central melanocortin system and energy homeostasis. Trends Endocrinol. Metab. 10:1999;211-216.
9. Adan R.A.et al. Differential effects of melanocortin peptides on neural melanocortin receptors. Mol. Pharmacol. 46:1994;1182-1190.
10. Huszar D.et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
11. Chen W.et al. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell. 91:1997;789-798.
12. Nussey S.et al. Isolated congenital ACTH deficiency: a cleavage enzyme defect? Clin. Endocrinol. 39:1993;381-385.
13. Smith A.I., Funder J.W. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr. Rev. 9:1988;159-179.
14. Hung W., Migeon C.J. Hypoglycemia in a two-year-old boy with adrenocorticotropic hormone (ACTH) deficiency (probably isolated) and adrenal medullary unresponsiveness to insulin-induced hypoglycemia. J. Clin. Endocrinol. Metab. 28:1968;146-152.
15. Saeger W.et al. Hereditary selective hypopituitarism. Immunocytochemical studies of 2 cases with GH-cell hypoplasia and ACTH-cell hypoplasia. Verh. Dtsch. Ges. Pathol. 66:1982;419-422.
16. Ichiba Y., Goto T. Isolated corticotropin deficiency. Am. J. Dis. Child. 137:1983;1202-1203.
17. Kyllo J.H.et al. Linkage of congenital isolated adrenocorticotropic hormone deficiency to the corticotropin releasing hormone locus using simple sequence repeat polymorphisms. Am. J. Med. Genet. 62:1996;262-267.
18. Krude H.et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19:1998;155-157.
19. Kozak M. The scanning model for translation: an update. J. Cell Biol. 108:1989;229-241.
20. Hattori, S. et al. (1999) Homozygous mutation for proopiomelanocortin (POMC) gene causes congenital isolated adrenocorticotropin (ACTH) deficiency, early-onset obesity and less pigmented hair. Annual Meeting of The Endocrine Society, St Diego, P3-430 (abstr.).
21. Reid J.D. Congenital absence of the pituitary gland. J. Pediatr. 56:1960;658-664.
22. Clark A.J., Weber A. Adrenocorticotropin insensitivity syndromes. Endocr. Rev. 19:1998;828-843.
23. Ellaway C.J.et al. Cholestatic jaundice and congenital hypopituitarism. J. Paediatr. Child Health. 31:1995;51-53.
24. Cone R.et al. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog. Horm. Res. 51:1996;287-317. discussion 318.
25. Tronche F.et al. Genetic dissection of glucocorticoid receptor function in mice. Curr. Opin. Genet. Dev. 8:1998;532-538.
26. Muglia L.et al. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature. 373:1995;427-432.
27. Olson G.A.et al. Endogenous opiates: 1996. Peptides. 18:1997;1651-1688.
28. Rubinstein M.et al. Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 93:1996;3995-4000.
29. Konig M.et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature. 383:1996;535-538.
30. Siracusa L.D. The agouti gene: turned on to yellow. Trends Genet. 10:1994;423-428.
31. Joerg H.et al. Red coat color in Holstein cattle is associated with a deletion in the MSHR gene. Mamm. Genome. 7:1996;317-318.
32. Pears R.et al. A case of skin hyperpigmentation due to alpha-MSH hypersecretion. Br. J. Dermatol. 126:1992;286-289.
33. Valverde P.et al. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet. 11:1995;328-330.
34. Schauer E.et al. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J. Clin. Invest. 93:1994;2258-2262.
35. Slominski A.et al. Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett. 374:1995;113-116.
36. Robertson B.et al. Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1 inducible biologic responses. J. Immunol. 140:1988;4300-4307.
37. Fan W.et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
38. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature. 395:1998;763-770.
39. Leibel R.L.et al. The molecular genetics of rodent single gene obesities. J. Biol. Chem. 272:1997;31937-31940.
40. Ollmann M.M.et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 278:1997;135-138.
41. Graham M.et al. Overexpression of Agrp leads to obesity in transgenic mice. Nat. Genet. 17:1997;273-274.
42. Montague C.T.et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:1997;903-908.
43. Clement K.et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392:1998;398-401.
44. Jackson R.S.et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16:1997;303-306.
45. Vaisse C.et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20:1998;113-114.
46. Yeo G.S.et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20:1998;111-112.
47. Hinney A.et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J. Clin. Endocrinol. Metab. 84:1999;1483-1486.
48. Frigeri L.G.et al. Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) F1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity. Int. J. Obes. 12:1988;305-320.
49. Hinney A.et al. Systematic mutation screening of the pro-opiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes. J. Clin. Endocrinol. Metab. 83:1998;3737-3741.
50. Comuzzie A.G.et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat. Genet. 15:1997;273-276.
51. Hager J.et al. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat. Genet. 20:1998;304-308.
52. Young J.I.et al. Authentic cell-specific and developmentally regulated expression of pro-opiomelanocortin genomic fragments in hypothalamic and hindbrain neurons of transgenic mice. J. Neurosci. 18:1998;6631-6640.
53. Takahashi H.et al. Isolation and structural organization of the human corticotropin-beta-lipotropin precursor gene. FEBS Lett. 135:1981;97-102.
54. Zhou A., Mains R.E. Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. J. Biol. Chem. 269:1994;17440-17447.
55. Borsodi A., Toth G. Characterization of opioid receptor types and subtypes with new ligands. Ann. New York Acad. Sci. 757:1995;339-352.
56. Reisine T., Bell G.I. Molecular biology of opioid receptors. Trends Neurosci. 16:1993;506-510.
57. Yaswen L.et al. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med. 5:1999;1066-1070.